News for AC Immune SA (IMR.BE)

Pune, India, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer's drugs which in turn is ...

February 12, 2021 (Investorideas.com Newswire) Shares of AC Immune SA traded 15% higher after the firm reported that interim results from the Phase 1b/2a Alzhei...

Shares of AC Immune SA (ACIU) are currently gaining 35% on Thursday morning after the Switzerland-based clinical-stage biopharmaceutical company announced positive interim results from ongoing mid-stage trial in older patients with early Alzheimer's disease.